95 related articles for article (PubMed ID: 18855579)
1. 2-Chloroadenosine and human prostate cancer cells.
Bellezza I; Tucci A; Minelli A
Anticancer Agents Med Chem; 2008 Oct; 8(7):783-9. PubMed ID: 18855579
[TBL] [Abstract][Full Text] [Related]
2. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
[TBL] [Abstract][Full Text] [Related]
3. 2-chloroadenosine modulates PAR-1 and IL-23 expression and enhances docetaxel effects on PC3 cells.
Minelli A; Bellezza I; Tucci A; Conte C; Bracarda S; Culig Z
Prostate; 2008 Mar; 68(4):360-72. PubMed ID: 18189232
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of 2-chloroadenosine toxicity to PC3 cell line.
Minelli A; Bellezza I; Agostini M; Bracarda S; Culig Z
Prostate; 2006 Sep; 66(13):1425-36. PubMed ID: 16741921
[TBL] [Abstract][Full Text] [Related]
5. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by 2-chloro-adenosine and 2-chloro-2'-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance.
Ceruti S; Franceschi C; Barbieri D; Malorni W; Camurri A; Giammarioli AM; Ambrosini A; Racagni G; Cattabeni F; Abbracchio MP
J Neurosci Res; 2000 May; 60(3):388-400. PubMed ID: 10797542
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
8. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
[TBL] [Abstract][Full Text] [Related]
9. E2F1 enhances 8-chloro-adenosine-induced G2/M arrest and apoptosis in A549 and H1299 lung cancer cells.
Duan HY; Cao JX; Qi JJ; Wu GS; Li SY; An GS; Jia HT; Cai WW; Ni JH
Biochemistry (Mosc); 2012 Mar; 77(3):261-9. PubMed ID: 22803943
[TBL] [Abstract][Full Text] [Related]
10. Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.
Zuco V; Supino R; De Cesare M; Carenini N; Perego P; Gatti L; Pratesi G; Pisano C; Martinelli R; Bucci F; Zanier R; Carminati P; Zunino F
Biochem Pharmacol; 2003 Apr; 65(8):1281-94. PubMed ID: 12694869
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression.
Fabbri F; Brigliadori G; Carloni S; Ulivi P; Tesei A; Silvestrini R; Amadori D; Zoli W
Prostate; 2010 Feb; 70(2):219-27. PubMed ID: 19790230
[TBL] [Abstract][Full Text] [Related]
13. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
[TBL] [Abstract][Full Text] [Related]
14. Differential molecular mechanism of docetaxel-octreotide combined treatment according to the docetaxel-resistance status in PC3 prostate cancer cells.
Lattanzio L; Tonissi F; Monteverde M; Milano G; Merlano MC; Lo Nigro C
Anticancer Drugs; 2013 Feb; 24(2):120-30. PubMed ID: 22990129
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of cell death induced by 2-chloroadenosine in leukemic B-cells.
Bastin-Coyette L; Smal C; Cardoen S; Saussoy P; Van den Neste E; Bontemps F
Biochem Pharmacol; 2008 Apr; 75(7):1451-60. PubMed ID: 18242582
[TBL] [Abstract][Full Text] [Related]
16. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
17. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
[TBL] [Abstract][Full Text] [Related]
18. 8-chloroadenosine induced HL-60 cell growth inhibition, differentiation, and G(0)/G(1) arrest involves attenuated cyclin D1 and telomerase and up-regulated p21(WAF1/CIP1).
Zhu B; Zhang LH; Zhao YM; Cui JR; Strada SJ
J Cell Biochem; 2006 Jan; 97(1):166-77. PubMed ID: 16173047
[TBL] [Abstract][Full Text] [Related]
19. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
20. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
